Lichter Jay
Insider CIK 1376355 · OTIC Director, 10% owner · PETX Director, 10% owner · THOR Director, 10% owner · JANX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 102,732 | $50.30 | $5.17M | 2,629,085 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 19,900 | $50.30 | $1.00M | 509,273 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 104,892 | $50.30 | $5.28M | 2,684,380 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 15,462 | $51.18 | $791.3K | 2,613,623 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 2,995 | $51.18 | $153.3K | 506,278 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 15,788 | $51.18 | $808.0K | 2,668,592 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 104,957 | $44.75 | $4.70M | 401,321 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 553,219 | $44.75 | $24.76M | 2,115,373 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 541,824 | $44.75 | $24.25M | 2,071,799 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-17 | 2024-10-18 | 348 | — | $0 | 9,142 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-17 | 2024-10-18 | 348 | — | $0 | 9,142 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-17 | 2024-10-18 | 836 | — | $0 | 21,940 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-17 | 2024-10-18 | 237 | — | $0 | 6,072 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-17 | 2024-10-18 | 1,843 | $50.02 | $92.2K | 6,371 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-17 | 2024-10-18 | 237 | $39.80 | $9.4K | 8,214 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-17 | 2024-10-18 | 836 | $17.00 | $14.2K | 7,281 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-17 | 2024-10-18 | 348 | $10.73 | $3.7K | 7,629 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-17 | 2024-10-18 | 348 | $13.22 | $4.6K | 7,977 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-16 | 2024-10-18 | 1,407 | — | $0 | 6,309 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-16 | 2024-10-18 | 4,968 | — | $0 | 22,776 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-16 | 2024-10-18 | 2,070 | — | $0 | 9,490 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-16 | 2024-10-18 | 2,070 | — | $0 | 9,490 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 60,179 | $49.69 | $2.99M | 2,761,291 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 11,657 | $49.69 | $579.2K | 534,883 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 61,445 | $49.69 | $3.05M | 2,819,366 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 29,474 | $50.61 | $1.49M | 2,731,817 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 5,710 | $50.61 | $289.0K | 529,173 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 30,094 | $50.61 | $1.52M | 2,789,272 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-16 | 2024-10-18 | 4,968 | $17.00 | $84.5K | 11,855 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-16 | 2024-10-18 | 2,070 | $10.73 | $22.2K | 13,925 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-16 | 2024-10-18 | 2,070 | $13.22 | $27.4K | 15,995 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-16 | 2024-10-18 | 1,407 | $39.80 | $56.0K | 17,402 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 10,957 | $50.80 | $556.6K | 6,445 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-30 | 2024-09-30 | 434 | — | $0 | 27,744 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-30 | 2024-09-30 | 181 | — | $0 | 11,560 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-30 | 2024-09-30 | 181 | — | $0 | 11,560 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-30 | 2024-09-30 | 123 | — | $0 | 7,716 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-30 | 2024-09-30 | 434 | $17.00 | $7.4K | 7,360 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-30 | 2024-09-30 | 181 | $10.73 | $1.9K | 7,541 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-30 | 2024-09-30 | 181 | $13.22 | $2.4K | 7,722 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-30 | 2024-09-30 | 123 | $39.80 | $4.9K | 7,845 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-30 | 2024-09-30 | 958 | $46.24 | $44.3K | 6,887 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-27 | 2024-09-30 | 828 | — | $0 | 28,178 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-27 | 2024-09-30 | 345 | — | $0 | 11,741 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-27 | 2024-09-30 | 234 | — | $0 | 7,839 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-27 | 2024-09-30 | 345 | — | $0 | 11,741 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 1,826 | $46.19 | $84.3K | 6,926 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-27 | 2024-09-30 | 234 | $39.80 | $9.3K | 8,752 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-27 | 2024-09-30 | 345 | $13.22 | $4.6K | 8,518 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-27 | 2024-09-30 | 345 | $10.73 | $3.7K | 8,173 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-27 | 2024-09-30 | 828 | $17.00 | $14.1K | 7,828 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 1,542 | $47.74 | $73.6K | 2,880,811 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 293 | $47.74 | $14.0K | 546,540 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 1,511 | $47.74 | $72.1K | 2,821,470 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 46,861 | $46.42 | $2.18M | 2,882,353 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 45,894 | $46.42 | $2.13M | 2,822,981 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 8,894 | $46.42 | $412.9K | 546,833 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 41,661 | $47.77 | $1.99M | 2,929,214 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 7,908 | $47.77 | $377.8K | 555,727 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 40,803 | $47.77 | $1.95M | 2,868,875 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 50,539 | $46.78 | $2.36M | 2,970,875 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 9,592 | $46.78 | $448.7K | 563,635 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 49,497 | $46.78 | $2.32M | 2,909,678 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-13 | 2024-10-24 | 391 | — | $0 | 7,682 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-13 | 2024-10-24 | 778 | — | $0 | 11,308 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-13 | 2024-10-24 | 778 | — | $0 | 11,308 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-13 | 2024-10-24 | 1,868 | — | $0 | 27,138 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-13 | 2024-10-24 | 3,815 | $46.68 | $178.1K | 7,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-13 | 2024-10-24 | 1,868 | $17.00 | $31.8K | 8,868 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-13 | 2024-10-24 | 778 | $10.73 | $8.3K | 9,646 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-13 | 2024-10-24 | 778 | $13.22 | $10.3K | 10,424 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-13 | 2024-10-24 | 391 | $39.80 | $15.6K | 10,815 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-12 | 2024-09-12 | 158,031 | $47.00 | $7.43M | 2,959,175 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-12 | 2024-09-12 | 161,356 | $47.00 | $7.58M | 3,021,414 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-12 | 2024-09-12 | 30,613 | $47.00 | $1.44M | 573,227 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 35,047 | $46.66 | $1.64M | 3,182,770 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 6,649 | $46.66 | $310.2K | 603,840 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 34,326 | $46.66 | $1.60M | 3,117,206 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 11,557 | $46.13 | $533.1K | 3,217,817 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 2,193 | $46.13 | $101.2K | 610,489 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 11,319 | $46.13 | $522.1K | 3,151,532 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-09 | 2024-09-10 | 414 | — | $0 | 12,086 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-09 | 2024-09-10 | 414 | — | $0 | 12,086 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-09 | 2024-09-10 | 994 | — | $0 | 29,006 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-09 | 2024-09-10 | 277 | — | $0 | 8,073 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-09 | 2024-09-10 | 994 | $17.00 | $16.9K | 8,077 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-09 | 2024-09-10 | 414 | $10.73 | $4.4K | 8,491 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-09 | 2024-09-10 | 277 | $39.80 | $11.0K | 9,182 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-09 | 2024-09-10 | 2,182 | $42.33 | $92.4K | 7,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-09 | 2024-09-10 | 414 | $13.22 | $5.5K | 8,905 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-06 | 2024-09-10 | 110,644 | $42.00 | $4.65M | 3,229,374 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-06 | 2024-09-10 | 20,991 | $42.00 | $881.6K | 612,682 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-06 | 2024-09-10 | 108,365 | $42.00 | $4.55M | 3,162,851 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 8,350 | — | $0 | 8,350 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2024-06-26 | 2024-06-28 | 2,500 | — | $0 | 7,083 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 691,525 | $54.75 | $37.86M | 3,340,018 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 131,196 | $54.75 | $7.18M | 633,673 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 677,279 | $54.75 | $37.08M | 3,271,216 | SEC↗ |
| JANX Janux Therapeutics, Inc. | P Buy | 2023-11-13 | 2023-11-15 | 849,854 | $5.87 | $4.99M | 849,854 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2022-06-21 | 2022-06-23 | 27,500 | — | $0 | 27,500 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2022-06-14 | 2022-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2021-06-22 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 1,859,634 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 2,105,264 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 900,264 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 888,888 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 526,316 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 1,138,665 | — | $0 | 1,330,815 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 674,211 | — | $0 | 4,387,217 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 2,696,843 | — | $0 | 2,696,843 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 1,153,238 | — | $0 | 3,850,081 | SEC↗ |
| JANX Janux Therapeutics, Inc. | P Buy | 2021-06-15 | 2021-06-16 | 629,411 | $17.00 | $10.70M | 4,479,492 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 2,382,191 | — | $0 | 3,713,006 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-03-03 | 2021-03-03 | 113,935 | $2.70 | $307.6K | 0 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-03-03 | 2021-03-03 | 207,245 | $2.70 | $559.6K | 0 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-03-02 | 2021-03-02 | 138,199 | $2.90 | $400.8K | 113,935 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-03-02 | 2021-03-02 | 251,375 | $2.90 | $729.0K | 207,245 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-03-01 | 2021-03-02 | 61,619 | $2.86 | $176.2K | 252,134 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-03-01 | 2021-03-02 | 112,081 | $2.86 | $320.6K | 458,620 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-02-26 | 2021-03-02 | 117,262 | $2.83 | $331.9K | 313,753 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-02-26 | 2021-03-02 | 213,292 | $2.83 | $603.6K | 570,701 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-02-25 | 2021-02-25 | 200,739 | $2.95 | $592.2K | 783,993 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-02-25 | 2021-02-25 | 110,361 | $2.95 | $325.6K | 431,015 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-02-24 | 2021-02-25 | 178,484 | $2.98 | $531.9K | 541,376 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-02-24 | 2021-02-25 | 324,651 | $2.98 | $967.5K | 984,732 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-02-23 | 2021-02-25 | 95,113 | $2.89 | $274.9K | 719,860 | SEC↗ |
| OTIC OTONOMY, INC. | S Sale | 2021-02-23 | 2021-02-25 | 173,005 | $2.89 | $500.0K | 1,309,383 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2020-06-23 | 2020-06-25 | 17,500 | — | $0 | 17,500 | SEC↗ |
| THOR Synthorx, Inc. | D To issuer deriv | 2020-01-23 | 2020-01-24 | 15,335 | $55.60 | $852.6K | 0 | SEC↗ |
| THOR Synthorx, Inc. | D To issuer deriv | 2020-01-23 | 2020-01-24 | 30,000 | $57.00 | $1.71M | 0 | SEC↗ |
| THOR Synthorx, Inc. | U Tender | 2020-01-23 | 2020-01-24 | 448,567 | $68.00 | $30.50M | 0 | SEC↗ |
| THOR Synthorx, Inc. | U Tender | 2020-01-23 | 2020-01-24 | 1,682,086 | $68.00 | $114.38M | 0 | SEC↗ |
| THOR Synthorx, Inc. | U Tender | 2020-01-23 | 2020-01-24 | 150,000 | $68.00 | $10.20M | 0 | SEC↗ |
| THOR Synthorx, Inc. | J Other | 2020-01-14 | 2020-01-16 | 448,567 | — | $0 | 448,567 | SEC↗ |
| THOR Synthorx, Inc. | J Other | 2020-01-14 | 2020-01-16 | 4,598,796 | — | $0 | 150,000 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2019-06-11 | 2019-06-13 | 17,500 | — | $0 | 17,500 | SEC↗ |
| THOR Synthorx, Inc. | A Award deriv | 2019-06-07 | 2019-06-10 | 15,335 | — | $0 | 15,335 | SEC↗ |
| THOR Synthorx, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 4,033,283 | — | $0 | 0 | SEC↗ |
| THOR Synthorx, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 1,221,896 | — | $0 | 0 | SEC↗ |
| THOR Synthorx, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 2,053,534 | — | $0 | 0 | SEC↗ |
| THOR Synthorx, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 1,821,156 | — | $0 | 0 | SEC↗ |
| THOR Synthorx, Inc. | P Buy | 2018-12-11 | 2018-12-13 | 545,455 | $11.00 | $6.00M | 1,682,086 | SEC↗ |
| THOR Synthorx, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 1,281,664 | — | $0 | 1,468,901 | SEC↗ |
| THOR Synthorx, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 762,617 | — | $0 | 2,231,518 | SEC↗ |
| THOR Synthorx, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 2,517,278 | — | $0 | 4,748,796 | SEC↗ |
| THOR Synthorx, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 1,136,631 | — | $0 | 1,136,631 | SEC↗ |
| THOR Synthorx, Inc. | A Award deriv | 2018-12-06 | 2018-12-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2018-06-19 | 2018-06-20 | 17,500 | — | $0 | 17,500 | SEC↗ |
| OTIC OTONOMY, INC. | M Exercise deriv | 2017-08-31 | 2017-09-05 | 14,106 | — | $0 | 0 | SEC↗ |
| OTIC OTONOMY, INC. | M Exercise deriv | 2017-08-31 | 2017-09-05 | 14,106 | — | $0 | 0 | SEC↗ |
| OTIC OTONOMY, INC. | M Exercise deriv | 2017-08-31 | 2017-09-05 | 14,106 | — | $0 | 0 | SEC↗ |
| OTIC OTONOMY, INC. | M Exercise deriv | 2017-08-31 | 2017-09-05 | 14,106 | — | $0 | 0 | SEC↗ |
| OTIC OTONOMY, INC. | M Exercise deriv | 2017-08-31 | 2017-09-05 | 14,106 | — | $0 | 0 | SEC↗ |
| OTIC OTONOMY, INC. | M Exercise deriv | 2017-08-31 | 2017-09-05 | 14,106 | — | $0 | 0 | SEC↗ |
| OTIC OTONOMY, INC. | M Exercise deriv | 2017-08-31 | 2017-09-05 | 14,106 | — | $0 | 0 | SEC↗ |
| OTIC OTONOMY, INC. | M Exercise deriv | 2017-08-31 | 2017-09-05 | 14,106 | — | $0 | 0 | SEC↗ |
| OTIC OTONOMY, INC. | M Exercise deriv | 2017-08-31 | 2017-09-05 | 14,106 | — | $0 | 0 | SEC↗ |
| OTIC OTONOMY, INC. | M Exercise deriv | 2017-08-31 | 2017-09-05 | 14,106 | — | $0 | 0 | SEC↗ |
| OTIC OTONOMY, INC. | M Exercise | 2017-08-31 | 2017-09-05 | 141,060 | $14.18 | $2.00M | 2,406,212 | SEC↗ |
| OTIC OTONOMY, INC. | F Tax w/h | 2017-08-31 | 2017-09-05 | 108,851 | $18.37 | $2.00M | 2,297,361 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2017-06-20 | 2017-07-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OTIC Otonomy, Inc. | A Award deriv | 2016-06-21 | 2016-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | J Other | 2015-07-15 | 2015-07-17 | 1,000,000 | — | $0 | 2,345,543 | SEC↗ |
| OTIC Otonomy, Inc. | A Award deriv | 2015-06-19 | 2015-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2015-06-18 | 2015-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 91,011 | — | $0 | 91,011 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 91,011 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 14,106 | — | $0 | 14,106 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 6,432 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 14,106 | — | $0 | 14,106 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 6,432 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 14,106 | — | $0 | 14,106 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 6,432 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 14,106 | — | $0 | 14,106 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 6,432 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 14,106 | — | $0 | 14,106 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 6,432 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 14,106 | — | $0 | 14,106 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 6,432 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 14,106 | — | $0 | 14,106 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 14,106 | — | $0 | 14,106 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 6,432 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 14,106 | — | $0 | 14,106 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 6,432 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 14,106 | — | $0 | 14,106 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 6,432 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 136,770 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 568,828 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 484,691 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 175,889 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 337,432 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion deriv | 2014-08-18 | 2014-08-19 | 6,432 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | X Exercise deriv | 2014-08-18 | 2014-08-19 | 91,011 | — | $0 | 0 | SEC↗ |
| OTIC Otonomy, Inc. | X Exercise | 2014-08-18 | 2014-08-19 | 91,011 | $8.79 | $800.0K | 1,500,180 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion | 2014-08-18 | 2014-08-19 | 705,598 | — | $0 | 705,598 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2014-08-18 | 2014-08-19 | 50,001 | $16.00 | $800.0K | 1,450,179 | SEC↗ |
| OTIC Otonomy, Inc. | P Buy | 2014-08-18 | 2014-08-19 | 109,375 | $16.00 | $1.75M | 814,973 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion | 2014-08-18 | 2014-08-19 | 660,580 | — | $0 | 1,409,169 | SEC↗ |
| OTIC Otonomy, Inc. | C Conversion | 2014-08-18 | 2014-08-19 | 740,057 | — | $0 | 748,589 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2014-06-19 | 2014-06-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2014-02-03 | 2014-02-05 | 825,000 | $19.00 | $15.68M | 3,345,543 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | P Buy | 2013-07-02 | 2014-02-04 | 500,000 | $6.00 | $3.00M | 4,170,543 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion deriv | 2013-07-02 | 2013-07-03 | 1,333,333 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion deriv | 2013-07-02 | 2013-07-03 | 375,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion deriv | 2013-07-02 | 2013-07-03 | 4,000,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion | 2013-07-02 | 2013-07-03 | 3,434,616 | — | $0 | 3,670,545 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2013-06-26 | 2013-06-28 | 21,058 | — | $0 | 21,058 | SEC↗ |